| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Anavex Life Sciences (NASDAQ:AVXL) will release its quarterly earnings report on Tuesday, 2025-08-12. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Anavex Life Sciences to report an earnings per share (EPS) of $-0.14.
Anticipation surrounds Anavex Life Sciences's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
The company's EPS beat by $0.02 in the last quarter, leading to a 0.62% increase in the share price on the following day.
Here's a look at Anavex Life Sciences's past performance and the resulting price change:
| Quarter | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.15 | -0.17 | -0.17 | -0.13 |
| EPS Actual | -0.13 | -0.14 | -0.14 | -0.14 |
| Price Change % | 1.0% | -3.0% | -3.0% | -11.0% |
Shares of Anavex Life Sciences were trading at $11.08 as of August 08. Over the last 52-week period, shares are up 75.86%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
To track all earnings releases for Anavex Life Sciences visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: AVXL
